Transcriptional initiation and elongation processes rely on an intricate interplay of proteins, co-factors, and chemical modulators. The small subunit of TFIID, TAF9, plays a crucial role in this context, binding to other transcriptional factors to enable RNA polymerase II-based transcription. Various chemicals have been identified that can either directly or indirectly influence the activity of TAF9. Their modes of action often revolve around the modulation of epigenetic markers like histone modifications. For instance, histone acetylation and methylation are critical determinants of gene expression, influencing the accessibility of the DNA template to the transcriptional machinery. Chemicals like Trichostatin A and 5-Azacytidine work by influencing these modifications – the former inhibits histone deacetylases leading to enhanced histone acetylation, while the latter impedes DNA methylation.
Another avenue through which these activators operate is the modulation of key kinases or proteins that have an indirect bearing on transcription initiation. For example, DRB, a compound that inhibits the phosphorylation of RNA polymerase II, can affect the assembly and function of the pre-initiation complex. Similarly, ZM 336372, a Raf kinase, by modulating the MAPK pathway, can have downstream effects on transcriptional regulation. Moreover, chemicals like BIO specifically target kinases like GSK-3, which have roles in diverse cellular processes including transcription. By inhibiting such kinases, these chemicals can create a cellular environment conducive to the action of transcription factors, such as TAF9, in the initiation process. The selected chemicals provide insights into the complexity of transcriptional regulation and underscore the of chemical modulators in refining our understanding of these processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor which promotes hyperacetylation of histones, enhancing TFIID's binding affinity to promoter regions and indirectly upregulating TAF9 function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can repress gene silencing, thereby promoting the function of TAF9 and other transcriptional factors. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Histone acetyltransferase inhibitor. By modulating histone acetylation, it can indirectly influence TAF9's role in transcription initiation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
Specific inhibitor of histone acetyltransferase p300, modifying chromatin structure and potentially promoting TAF9's association with TFIID complex. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II CTD phosphorylation, potentially promoting pre-initiation complex formation involving TAF9. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $46.00 | 2 | |
Raf kinase inhibitor that indirectly modulates the downstream MAPK pathway. This can modify the dynamics of transcriptional regulators, potentially affecting TAF9. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
GSK-3 inhibitor that can regulate transcriptional activities and indirectly modulate the function of TAF9 within the TFIID complex. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Histone deacetylase inhibitor that enhances acetylation of histones, potentially promoting TAF9's interaction with transcription complexes. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $36.00 $110.00 $400.00 | ||
G9a histone methyltransferase inhibitor. By influencing histone methylation, it can potentially affect TAF9's role in transcription initiation. | ||||||
PFI-1 | 1403764-72-6 | sc-478504 | 5 mg | $96.00 | ||
BET bromodomain inhibitor. Through modifying bromodomain interactions, it indirectly influences TFIID components, including TAF9. | ||||||